Skip to main content
. 2021 May 28;10(6):866. doi: 10.3390/antiox10060866

Figure 2.

Figure 2

Figure 2

Figure 2

Changes in plasma and urinary (A) L-FABP, (B) NGAL, (C) KIM-1, (D) RBP-4, (E) I-FABP, (F) I-BABP, (G) LBP and (H) myoglobin. Values are presented as mean ± SE. * p < 0.05, ** p < 0.01, *** p < 0.001 vs. Pre. † p < 0.05 REH vs. CON in each time point. L-FABP, liver-fatty acid binding protein; NGAL, neutrophil gelatinase-associated lipocalin; KIM-1, kidney injury molecule 1; RBP-4, retinol binding protein 4; I-FABP, intestine-fatty acid binding protein; I-BABP, ileal-bile acid binding protein; LBP, lipopolysaccharide binding protein; REH, rehydrate trial; CON, control trial.